Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design

被引：0
|
作者：
Andrew J Stephenson
机构：
[1] AJ Stephenson is an Assistant Professor of Urology at the Cleveland Clinic Lerner College of Medicine and Associate Attending Staff in the Section of Urologic Oncology at the Glickman Urological Institute,
[2] Cleveland Clinic Foundation,undefined
[3] Cleveland,undefined
[4] OH,undefined
[5] USA.,undefined
来源：
Nature Clinical Practice Urology | 2007年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：362 / 363
页数：1
相关论文
共 50 条
  • [1] Identifying patients at risk for prostate-cancer-specific mortality: implications for clinical trial design
    Stephenson, Andrew J.
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (07): : 362 - 363
  • [2] Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer
    Xu, Chaojie
    Pei, Dongchen
    Liu, Yi
    Guo, Jianhua
    Liu, Nan
    Wang, Qian
    Yu, Yang
    Kang, Zhengjun
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Impact of surgical margin status on prostate-cancer-specific mortality
    Chalfin, Heather J.
    Dinizo, Michael
    Trock, Bruce J.
    Feng, Zhaoyong
    Partin, Alan W.
    Walsh, Patrick C.
    Humphreys, Elizabeth
    Han, Misop
    BJU INTERNATIONAL, 2012, 110 (11) : 1684 - 1689
  • [4] How socioeconomic and clinical factors impact prostate-cancer-specific and other-cause mortality in prostate cancer stratified by clinical stage: Competing-risk analysis
    He, Hairong
    Han, Didi
    Xu, Fengshuo
    Lyu, Jun
    PROSTATE, 2022, 82 (04) : 415 - 424
  • [5] Predicting prostate-cancer-specific death: Is it in the cancer?
    Ayala, G. E.
    Miles, B. J.
    Freund, C. T.
    Li, R.
    Frolov, A.
    Ittmann, M. M.
    Kadmon, D.
    Scardino, P. T.
    Wheeler, T.
    Rowley, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Time to biochemical failure predicts distant metastases and prostate-cancer-specific mortality
    Nature Clinical Practice Urology, 2008, 5 (4): : 181 - 181
  • [7] Time to biochemical failure predicts distant metastases and prostate-cancer-specific mortality
    Nature Clinical Practice Oncology, 2008, 5 (3): : 124 - 124
  • [8] Is pretreatment PSA velocity associated with prostate-cancer-specific mortality rate after radiotherapy?
    Alan Pollack
    Nature Clinical Practice Urology, 2006, 3 (1): : 12 - 13
  • [9] Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities
    Dee, Edward Christopher
    Nezolosky, Michelle D.
    Chipidza, Fallon E.
    Arega, Melaku A.
    Butler, Santino S.
    Sha, Sybil T.
    Mahal, Brandon A.
    Nguyen, Paul L.
    Yang, David D.
    Muralidhar, Vinayak
    PROSTATE, 2020, 80 (13) : 1128 - 1133
  • [10] Metformin use and all-cause and prostate-cancer-specific mortality among diabetic men
    Margel, David
    Urbach, David R.
    Lipscombe, Lorraine
    Bell, Chaim
    Kilkarni, Girish
    Austin, Peter
    Joshua, Anthony Michael
    Fleshner, Neil Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345